Keyword: Physician Payments Sunshine Act
A doctor accused of ordering excessive pain drugs for dozens of Ohio hospital patients who died responded to one of the lawsuits filed against him.
Congress is expected to expand the Sunshine Act and require drug companies and medical device manufacturers to disclose payments to more clinicians.
Doctors and teaching hospitals received $8.4 billion in payments from drug companies in 2017 and more physician practice news.
A new ProPublica analysis shows that drugmakers spent less money to market opioids to doctors in 2016 than in prior years.
ProPublica this week updated its “Dollars for Docs” tool, which shows payments that doctors have received from pharmaceutical and medical device companies.
A significant piece of healthcare legislation will go up for a vote in the House, and the implications could be wide-reaching.
Dermatologists raked in over $34 million in industry payments, much of it from pharmaceutical companies, but how that affects patients remains unclear.
As sales reps from the medical industry lose their access to more physicians and practice groups, a new study suggests the influence of pharmaceutical advertising may be overstated.
Two years after the Physician Payment Sunshine Act, it’s still unclear how the legislation has influenced providers’ willingness to accept payments.
Federal investigators and prosecutors are mining CMS's Open Payments data to identify spending outliers and solidify whistleblower fraud claims.